Polymorphic Genes of Xenobiotic-Metabolizing Enzymes Associated with Predisposition to Bronchial Asthma in Hereditarily Burdened and Nonburdened Children

Russian Journal of Genetics

Volumn 38, Issue 4, 2002, Pages 439-445

  Vavilin, V A ^a   Makarova, S I ^a   Lyakhovich, V V ^a   Gavalov, S M ^b  

^a INSTITUTE OF MOLECULAR BIOLOGY AND BIOPHYSICS   (Russian Federation)

^b NOVOSIBIRSK STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0346985104     PISSN: 10227954     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015214606118     Document Type: Article

References (30)

1. Sandford, A., Weir, T., and Pare, P., Genetics of Asthma, Am. J. Respir. Crit. Care Med., 1995, vol. 153, no. 6, part 1, pp. 1749-1765.
2. Bronchial Asthma: Global Strategy, Pul'monologiya, 1996, suppl., pp. 11-13.
3. Oganov, R.G. and Maslennikova, G.Ya., Asthma Mortality in Russia between 1980 and 1989, Eur. Respir. J., 1999, vol. 13, no. 2, pp. 287-289.
4. Mulder, G.J., Metabolic Activation of Industrial Chemicals and Implications for Toxicity, Toxicology of Industrial Compounds, Thomas, H., Hess, R., and Waechter, F., Eds., London: Taylor and Fransis, 1995, pp. 37-44.
5. van Bladeren, P.J. and van Ommen, B., Metabolism of Reactive Chemicals, Toxicology of Industrial Compounds, Thomas, H., Hess, R., and Waechter, F., Eds., London: Taylor and Fransis, 1995, pp. 61-72.
6. Perera, F., Environment and Cancer: Who a Susceptible?, Science, 1997, vol. 278, no. 5340, pp. 1068-1073.
7. Wang, W. and Ballatori, N., Endogenous Glutathione Conjugates: Occurrence and Biological Functions, Pharmacol. Rev., 1998, vol. 50, no. 3, pp. 335-355.
8. Lyakhovich, V.V., Vavilin, V.A., Makarova, S.I., et al., The Role of Xenobiotic Biotransformation Enzymes in Predisposition to Bronchial Asthma and Formation of Its Specific Clinical Phenotype, Vestn. Ross. Akad. Med. Nauk, 2000, no. 12, pp. 36-41.
9. Schaid, D.J. and Rowland, C., Use of Parents, Sibs, and Unrelated Controls for Detection of Associations between Genetic Markers and Disease, Am. J. Hum. Genet., 1998, vol. 63, no. 5, pp. 1492-1506.
10. Kunkel, L.M., Smith, K.D., Boyer, S.H., et al., Analysis of Human Y-Chromosome-Specific Reiterated DNA in Chromosome Variants, Proc. Natl. Acad. Sci. USA, 1977, vol. 74, pp. 1245-1249.
11. Hayashi, S., Watanabe, J., Nakashi, K., and Kawajiri, K., Genetic Linkage of Lung Cancer-Associated MspI Polymorphisms with Amino Acid Replacement in the Heme-Binding Region of the Human Cytochrome P4501A1 Gene, J. Biochem., 1991, vol. 110, pp. 407-411.
12. Zhong, S., Wyllie, A.H., Barnes, D., et al., Relationship between the GSTM1 Genetic Polymorphism and Susceptibility to Bladder, Breast and Colon Cancer, Carcinogenesis, 1993, vol. 14, no. 9, pp. 1821-1824.
13. Pemble, S., Schroeder, K.R., Spencer, S.R., et al., Human Glutathione S-Transferase Theta (GSTT1): cDNA Cloning and the Characterization of a Genetic Polymorphism, Biochem. J., 1994, vol. 300, part 1, pp. 271-276.
14. Gil, J.P. and Lechner, M.C., Increased Frequency of Wild-Type Arylamine-N-Acetyltransferase Allele NAT2*4 Homozygotes in Portuguese Patients with Colorectal Cancer, Carcinogenesis, 1998, vol. 19, no. 1, pp. 37-41.
15. Hein, D.W., Grant, D.M., and Sim, E., 2001, http://www.louisvill.edu/medschool/pharmacology/NAT.html.
16. Pearce, N., What Does the Odds Ratio Estimate in a Case-Control Study?, Int. J. Epidemiol., 1993, vol. 22, no. 6, pp. 1189-1192.
17. Deakin, M., Elder, J., Hendrickse, C., et al., Glutathione S-Transferase T1 Genotypes and Susceptibility to Cancer: Studies of Interactions with GSTM1 in Lung, Oral, Gastric and Colorectal Cancers, Carcinogenesis, 1996, vol. 17, pp. 881-884.
18. Warholm, M., Rane, A., Alexandrie, A.K., et al., Genotypic and Phenotypic Determination of Polymorphic Glutathione Transferase T1 in a Swedish Population, Pharmacogenetics, 1995, vol. 5, no. 4, pp. 252-254.
19. Drakoulis, N., Cascorbi, I., Brockmoller, J., et al., Polymorphisms in the Human CYP1A1 Gene as a Susceptibility Factors for Lung Cancer: Exon-7 Mutation (4889 A to G) and a T to C Mutation in the 3′-Flanking Region, Clin. Invest., 1994, vol. 72, no. 3, pp. 240-248.
20. Alexandrie, A.-K., Sundberg, M.I., Seidegard, J., et al., Genetic Susceptibility to Lung Cancer with Special Emphasis on CYP1A1 and GSTM1: A Study on Host Factors in Relation to Age at Onset, Gender and Histological Cancer Types, Carcinogenesis, 1994, vol. 15, no. 9, pp. 1785-1790.
21. Kalow, W., Interethnic Variation in Drug Metabolism, Trends Pharmacol. Sci., 1991, vol. 12, no. 3, pp. 102-107.
22. Seillier-Moiseiwitsch, F., Pinheiro, H., Li, H., and Newman, B., Identifying Genetic Markers to Assess the Presence of Gene-Environment Interactions, Genet. Epidemiol., 1997, vol. 14, no. 6, pp. 1041-1046.
23. Lyakhovich, V.V., Vavilin, V.A., Gutkina, N.I., et al., Genes and Enzymes of the Xenobiotic Metabolism System in Oncological Diseases, Vopr. Med. Khim., 1997, no. 5, pp. 330-338.
24. Bjorksten, B., The Environmental Influence on Childhood Asthma, Allergy, 1999, vol. 54, suppl. 49, pp. 17-23.
25. Kogevinas, M., Anto, J.M., Sunyer, J., et al., Occupational Asthma in Europe and Other Industrialized Areas: A Population-Based Study: European Community Respiratory Health Survey Study Group, Lancet, 1999, vol. 353, no. 9166, pp. 1750-1754.
26. Kim, W.J., Lee, H.L., Lee, S.L., et al., Polymorphisms of N-Acetyltransferase 2, Glutathione S-Transferase Mu and Theta Genes as Risk Factors of Bladder Cancer in Relation to Asthma and Tuberculosis, J. Urol., 2000, vol. 164, no. 1, pp. 209-213.
27. Khoury, M.J. and James, L.M., Population and Familiar Relative Risks of Disease Associated with Environmental Factors in the Presence of Gene-Environment Interaction, Am. J. Epidemiol., 1993, vol. 137, pp. 1241-1250.
28. Jansen, P.L., Diagnosis and Management of Crigler-Najjar Syndrome, Eur. J. Pediatr., 1999, vol. 158, suppl. 2, pp. S89-S94.
29. Stanic, M. and Nesovic, M., Congenital Adrenal Hyperplasia, Med. Pregl., 1999, vol. 52, nos. 11-12, pp. 447-454.
30. Stoilov, I., Akarsu, A.N., and Sarfarazi, M., Identification of Three Different Truncating Mutations in Cytochrome P4501B1 (CYP1B1) as the Principal Cause of Primary Congenital Glaucoma (Buphthalmos) in Families Linked to the GLC3A Locus on Chromosome 2p21, Hum. Mol. Genet., 1997, vol. 6, no. 4, pp. 641-647.